EAGLE PHARMACEUTICALS INC (EGRX) Forecast, Price Target & Analyst Ratings

NASDAQ:EGRX • US2697961082

Current stock price

2.14 USD
-1.42 (-39.89%)
At close:
2.28 USD
+0.14 (+6.54%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EAGLE PHARMACEUTICALS INC (EGRX).

Forecast Snapshot

Consensus Price Target

Price Target
$17.34
+ 710.28% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Nov 4, 2024
Period
Q3 / 2023
EPS Estimate
$1.11
Revenue Estimate
64.083M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.71%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$17.34
Upside
+ 710.28%
From current price of $2.14 to mean target of $17.34, Based on 7 analyst forecasts
Low
$17.17
Median
$17.34
High
$17.85

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for EGRX. The average price target is 17.34 USD. This implies a price increase of 710.28% is expected in the next year compared to the current price of 2.14.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

EGRX Current Analyst RatingEGRX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

EGRX Historical Analyst RatingsEGRX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
85.71%
EGRX was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about EGRX.
In the previous month the buy percentage consensus was at a similar level.
EGRX was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-08-09Piper SandlerDowngrade Neutral -> Underweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
Nov 4, 2024
Period
Q3 / 2023
EPS Estimate
$1.11
Revenue Estimate
64.083M
Revenue Q2Q
-2.76%
EPS Q2Q
-0.73%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

EGRX is expected to report earnings on 11/4/2024. The consensus EPS estimate for the next earnings is 1.11 USD and the consensus revenue estimate is 64.08M USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2023 - 2027

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
EGRX revenue by date.EGRX revenue by date.
187.8M
-4.13%		171.5M
-8.68%		316.6M
84.61%		263.51M
-16.77%		215.73M
-18.13%		228.48M
5.91%		320.69M
40.36%		330.48M
3.05%
EBITDA
YoY % growth
EGRX ebitda by date.EGRX ebitda by date.
36.54M
38.15%		6.56M
-82.05%		114.43M
1,644.36%		82.331M
-28.05%		60.872M
-26.06%		53.04M
-12.87%		N/AN/A
EBIT
YoY % growth
EGRX ebit by date.EGRX ebit by date.
33M
51.38%		2.8M
-91.52%		102.4M
3,557.14%		35.598M
-65.24%		11.628M
-67.34%		50.796M
336.84%		79.356M
56.22%		80.07M
0.90%
Operating Margin
EGRX operating margin by date.EGRX operating margin by date.
17.57%1.63%32.34%13.51%5.39%22.23%24.75%24.23%
EPS
YoY % growth
EGRX eps by date.EGRX eps by date.
3.54
36.68%		2.58
-27.12%		7.82
203.10%		4.67
-40.26%		3.34
-28.60%		3.05
-8.56%		4.27
40.13%		4.25
-0.48%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 23 Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		1.11
-0.73%		1.09
-0.78%		1.00
-20.67%		0.79
-33.44%		0.94
-15.60%		1.04
-4.67%
Revenue
Q2Q % growth		64.083M
-2.76%		65.804M
8.41%		58.854M
-11.24%		56.814M
-12.12%		52.53M
-18.03%		51.51M
-21.72%
EBITDA
Q2Q % growth		19.733M
6.66%		19.268M
-4.76%		N/AN/AN/AN/A
EBIT
Q2Q % growth		8.958M
-25.97%		8.492M
3.56%		11.22M
-4.92%		8.058M
-21.77%		11.832M
32.08%		17.544M
106.59%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

EGRX Yearly Revenue VS EstimatesEGRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
EGRX Yearly EPS VS EstimatesEGRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-26.94%
EPS Next 5 Year
-11.47%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-11.23%
Revenue Next 5 Year
0.24%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-26.19%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

EAGLE PHARMACEUTICALS INC / EGRX Forecast FAQ

Can you provide the average price target for EAGLE PHARMACEUTICALS INC stock?

7 analysts have analysed EGRX and the average price target is 17.34 USD. This implies a price increase of 710.28% is expected in the next year compared to the current price of 2.14.

When does EAGLE PHARMACEUTICALS INC (EGRX) report earnings?

EAGLE PHARMACEUTICALS INC (EGRX) will report earnings on 2024-11-04, after the market close.

What are the consensus estimates for EGRX stock next earnings?

The consensus EPS estimate for the next earnings of EAGLE PHARMACEUTICALS INC (EGRX) is 1.11 USD and the consensus revenue estimate is 64.08M USD.

What is the expected long term growth rate for EAGLE PHARMACEUTICALS INC (EGRX)?

The expected long term growth rate for EAGLE PHARMACEUTICALS INC (EGRX) is -11.22%.